Epidemiology of Prostate Cancer in Africa: Another Step in the Understanding of the Disease?

Current Problems in Cancer

Volumn 31, Issue 3, 2007, Pages 226-236

  Delongchamps, Nicolas B ^a   Singh, Amar ^a   Haas, Gabriel P ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; MIGRATION; PREVALENCE; PROGENY; PROSTATE CANCER;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; PREVALENCE; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 34249286193     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2007.01.004     Document Type: Article

References (47)

1. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 (2005) 1407-1427
2. Gueye S.M., Zeigler-Johnson C.M., Friebel T., et al. Clinical characteristics of prostate cancer in African Americans, Americans whites, and Senegalese men. Urology 61 (2003) 987-992
3. Echimane A.K., Ahnoux A.A., Aboubi I., et al. Cancer incidence in Abidjan, Ivory Coast. First results from the Cancer Registry, 1995-1997. Cancer 89 (2000) 653-663
4. Glover Jr. F.E., Coffey D.S., Douglas L.L., et al. The epidemiology of prostate cancer in Jamaica. J Urol 159 (1998) 1984-1986
5. Ravery V., Javerliat I., Toublanc M., et al. Features of prostatic cancer in French individuals of African-Caribbean origin. Prog Urol 10 (2000) 231-236
6. Antopoulos I.M., Pompeo A.C.L., El Hayek O.R., et al. Results of prostate cancer screening in non symptomatic men. Braz J Urol 27 (2001) 227-234
7. Brawley O.W. Prostate cancer and black men. Semin Urol Oncol 16 (1998) 184-186
8. Littrup P.J. Editorial: Prostate cancer in African-American men. Prostate 31 (1997) 139
9. Austin J.P., Aziz H., Potters L., et al. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 121 (1990) 761-762
10. Fowler Jr. J.E., Bigler S.A., Bowman G., and Kilambi N.K. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. J Urol 163 (2000) 137-142
11. Pienta K.J., Demers R., Hoff M., et al. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area: 1973 to 1987. Urology 45 (1995) 93-102
12. Powell I.J., Schwartz K., and Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival?. A comparative study between black and white men in a Veteran affairs system. Urology 46 (1995) 825-830
13. Powell I.J., Heilbrun L., Littrup P., et al. Outcome of African American men screened for prostate cancer, the DEED (Detroit Education and Early Detection) study. J Urol 158 (1997) 146-149
14. Tewari A., Horninger W., Pelzer A.E., et al. Factors contributing to the racial differences in prostate cancer mortality. BJU Int 96 (2005) 1247-1252
15. Ellis L., and Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57 (1992) 72-75
16. Schwartz G.G., and Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer?. (Hypothesis). Anticancer Res 10 (1990) 1307-1312
17. Buttyan R.S., Sawczuk I.S., Benson M.C., et al. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11 (1987) 327-337
18. Mettlin C., Selenkas S., Natarajan N., and Huben R. Betacarotene and animal fats and their relationship to prostate cancer risk. Cancer 64 (1989) 605-612
19. Carter B.S., Bova G.S., Beaty T.H., et al. Hereditary prostate cancer: epidemiological and clinical features. J Urol 150 (1993) 797-802
20. Smith J.R., Freije D., Carpten J.D., et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274 (1996) 1371-1374
21. Schaid D.J. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 13 (2004) 103-121
22. Bratt O., Kristoffersson U., Lundgren R., and Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 35 (1999) 272-277
23. Ukoli F., Osime U., Akereyeni F., et al. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol 10 (2003) 315-322
24. Bah E., Hall A.J., and Inskip H.M. The first 2 years of the Gambian National Cancer Registry. Br J Cancer 62 (1990) 647-650
25. Bayo S., Parkin D.M., Koumare A.K., et al. Cancer in Mali, 1987-1988. Int J Cancer 45 (1990) 679-684
26. Koulibali M., Kabba I.S., Cisse A., et al. Cancer incidence in Konakry, Guinea. First results from the Cancer Registry 1992-1995. Int J Cancer 70 (1997) 39-45
27. Parkin D.M., Whelan S.L., Ferlay J., et al. Cancer incidence in five continents, vol VII. IARC scientific publication no. 143 (1997), International Agency for Research on Cancer, Lyon, France
28. Chokunonga E., Levy L.M., Bassett M.T., et al. Cancer incidence in the African population of Harare, Zimbabwe: second results from the Cancer Registry 1993-1995. Int J Cancer 85 (2000) 54-59
29. Wabinga H.R., Parkin D.M., Wabwire Mangen F., and Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda 1960-1997. Br J Cancer 82 (2000) 1585-1592
30. Osegbe D.N. Prostate cancer in Nigerians: facts and nonfacts. J Urol 157 (1997) 1340-1343
31. Yatani R., Shiraishi T., Nakakuki K., et al. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 80 (1988) 683-687
32. Sakr W.A., Grignon D.J., Crissman J.D., et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8 (1994) 439-444
33. Guileyardo J.M., Johnson W.D., Welsh R.A., et al. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 65 (1980) 311-316
34. Denton S.E., Choy S.H., and Valk W.L. Occult prostate carcinoma diagnosed by the step-section technique of surgical specimen. J Urol 93 (1965) 296-298
35. Montie J.E., Wood Jr. D.P., Pontes J.E., Boyett J.M., and Levin H.S. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63 (1989) 381-385
36. Abbas F., Hochberg D., Civantos F., and Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 30 (1996) 322-326
37. Singh A., Kinoshita Y., Rovito Jr. P.M., et al. Higher than expected association of clinical prostate and bladder cancers. J Urol 173 (2005) 1526-1529
38. Akazaki K., and Stemmermann G.N. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 50 (1973) 1137-1144
39. Sanchez-Chapado M., Olmedilla G., Cabeza M., et al. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 54 (2003) 238-247
40. Breslow N., Chan C.W., Dhom G., et al., The International Agency for Research on Cancer, Lyons, France. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20 (1977) 680-688
41. Koug X.T., Xia T.L., and Gu F.L. Study of the latent carcinoma of prostate in China. BJU 80 (1997) A895
42. Stamatiou K., Alevizos A., Perimeni D., et al. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study. Prostate Cancer Prostatic Dis 9 (2006) 45-49
43. Soos G., Tsakiris I., Szanto J., et al. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 48 (2005) 739-744
44. Stemmermann G.N., Nomura A.M.Y., Chyou P.H., and Yatani R. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience. Cancer Epidemiol Biomarkers Prev 1 (1992) 189-193
45. Jackson M.A., Kovi J., Heshmat T.A., et al. Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate 1 (1980) 185-205
46. Dezso B., Soos G., Tsakiris I., and Haas G.P. Re: Differences of prostate cancer incidence on autopsy material between European Caucasian male populations (in response to Stamatiou KN, et al: Reply to Soos G, et al. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 2005;48(5):739-44). Eur Urol 49 6 (2006) 1139-1140
47. International Agency for Research on Cancer: Incidence of prostate cancer in Africa. Available from: http://www-dep.iarc.fr.